| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Dec 16, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -60,975 | -1.09% | ✓ | $4.6M |
| Dec 4, 2025 | Dec 8, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 38.8 | -80,000 | -1.42% | ✓ | $5.9M |
| Nov 20, 2025 | Nov 24, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 43.8 | -26,156 | -0.46% | ✓ | $1.7M |
| Nov 16, 2025 | Nov 18, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 27.5 | -32,855 | -0.58% | ✗ | $2.2M |
| Nov 6, 2025 | Nov 10, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -80,000 | -1.40% | ✓ | $5M |
| Oct 8, 2025 | Oct 10, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -80,000 | -1.38% | ✓ | $4.4M |
| Sep 4, 2025 | Sep 8, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -80,000 | -1.37% | ✓ | $4.2M |
| Aug 20, 2025 | Aug 22, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 43.8 | -26,156 | -0.44% | ✓ | $1.3M |
| Aug 16, 2025 | Aug 19, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 27.5 | -32,855 | -0.56% | ✗ | $1.7M |
| Aug 7, 2025 | Aug 11, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -80,000 | -1.35% | ✓ | $3.7M |
| Jul 1, 2025 | Jul 3, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -80,000 | -1.33% | ✓ | $3.4M |
| May 16, 2025 | May 20, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 36.3 | -134,010 | -2.18% | ✓ | $4.5M |
| Apr 22, 2025 | Apr 24, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -75,000 | -1.22% | ✓ | $2.6M |
| Mar 25, 2025 | Mar 27, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -75,000 | -1.20% | ✓ | $2.8M |
| Feb 25, 2025 | Feb 27, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -75,000 | -1.19% | ✓ | $2.5M |
| Feb 16, 2025 | Feb 19, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 42.5 | -55,539 | -0.87% | ✓ | $2M |
| Jan 28, 2025 | Jan 30, 2025 | BridgeBio Pharma, Inc. | CEO | Sell | 21.3 | -600,000 | -8.69% | ✓ | $21.8M |
| Nov 19, 2024 | Nov 20, 2024 | BridgeBio Pharma, Inc. | CEO | Sell | 46.3 | -27,389 | -0.40% | ✓ | $613.8K |
| Nov 16, 2024 | Nov 19, 2024 | BridgeBio Pharma, Inc. | CEO | Sell | 37.5 | -28,148 | -0.40% | ✗ | $667.7K |
| Aug 16, 2024 | Aug 20, 2024 | BridgeBio Pharma, Inc. | CEO | Sell | 43.8 | -55,537 | -0.33% | ✓ | $1.4M |
| May 16, 2024 | May 17, 2024 | BridgeBio Pharma, Inc. | CEO | Sell | 37.5 | -30,748 | -0.44% | ✗ | $954.4K |
| Feb 16, 2024 | Feb 21, 2024 | BridgeBio Pharma, Inc. | CEO | Sell | 27.5 | -47,922 | -0.69% | ✗ | $1.8M |
| Nov 16, 2023 | Nov 20, 2023 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -102,249 | -1.48% | ✓ | $3M |
| Aug 16, 2023 | Aug 18, 2023 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -102,250 | -1.48% | ✓ | $3M |
| May 16, 2023 | May 18, 2023 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -102,249 | -1.48% | ✓ | $1.4M |
| May 3, 2023 | May 5, 2023 | BridgeBio Pharma, Inc. | CEO | Sell | 36.3 | -120,000 | -2.02% | ✓ | $1.7M |
| Apr 5, 2023 | Apr 7, 2023 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -120,000 | -1.98% | ✓ | $1.9M |
| Mar 3, 2023 | Mar 3, 2023 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -120,000 | -1.94% | ✓ | $1.3M |
| Feb 16, 2023 | Feb 21, 2023 | BridgeBio Pharma, Inc. | CEO | Sell | 45.0 | -68,706 | -0.95% | ✓ | $871.3K |
| Feb 3, 2023 | Feb 6, 2023 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -120,000 | -1.90% | ✓ | $1.3M |
| Jan 5, 2023 | Jan 6, 2023 | BridgeBio Pharma, Inc. | CEO | Sell | 42.5 | -120,000 | -1.87% | ✓ | $920.9K |
| Nov 16, 2022 | Nov 18, 2022 | BridgeBio Pharma, Inc. | CEO | Sell | 30.0 | -68,706 | -0.89% | ✗ | $654K |
| Aug 16, 2022 | Aug 18, 2022 | BridgeBio Pharma, Inc. | CEO | Sell | 37.5 | -27,697 | -0.36% | ✗ | $306.9K |
| May 16, 2022 | May 18, 2022 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -23,759 | -0.31% | ✗ | $160.1K |
| Feb 16, 2022 | Feb 18, 2022 | BridgeBio Pharma, Inc. | CEO | Sell | 51.3 | -3,085 | -0.04% | ✗ | $27.3K |
| Nov 16, 2021 | Nov 18, 2021 | BridgeBio Pharma, Inc. | CEO | Sell | 47.5 | -3,730 | -0.05% | ✗ | $176.2K |
| Aug 16, 2021 | Aug 18, 2021 | BridgeBio Pharma, Inc. | CEO | Sell | 47.5 | -3,730 | -0.05% | ✗ | $184.6K |
| May 16, 2021 | May 18, 2021 | BridgeBio Pharma, Inc. | CEO | Sell | 47.5 | -3,731 | -0.05% | ✗ | $200.2K |
| Feb 16, 2021 | Feb 18, 2021 | BridgeBio Pharma, Inc. | CEO | Buy | 62.5 | +13,861 | 0.18% | ✗ | $861K |
| Nov 16, 2020 | Nov 18, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 47.5 | -1,774 | -0.02% | ✗ | $78.6K |
| Aug 16, 2020 | Aug 18, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 47.5 | -1,774 | -0.02% | ✗ | $50.6K |
| Aug 3, 2020 | Aug 5, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -80,000 | -1.17% | ✓ | $2.2M |
| Jul 1, 2020 | Jul 6, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 36.3 | -143,470 | -2.05% | ✓ | $4.4M |
| Jun 8, 2020 | Jun 10, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 47.5 | -10,600 | -0.15% | ✓ | $318.1K |
| Jun 3, 2020 | Jun 5, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 51.3 | -5,930 | -0.08% | ✓ | $178.2K |
| Jun 1, 2020 | Jun 3, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -80,000 | -1.13% | ✓ | $2.3M |
| May 5, 2020 | May 6, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -79,600 | -1.11% | ✓ | $2.5M |
| May 1, 2020 | May 5, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -80,400 | -1.11% | ✓ | $2.4M |
| Apr 7, 2020 | Apr 9, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 57.5 | -1,805 | -0.02% | ✓ | $46K |
| Apr 3, 2020 | Apr 6, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 58.8 | -300 | 0.00% | ✓ | $7.5K |
| Apr 1, 2020 | Apr 3, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -77,895 | -1.06% | ✓ | $2M |
| Mar 2, 2020 | Mar 4, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 40.0 | -120,000 | -1.61% | ✓ | $3.9M |
| Feb 5, 2020 | Feb 7, 2020 | BridgeBio Pharma, Inc. | CEO | Sell | 43.8 | -30,893 | -0.41% | ✓ | $1.1M |
| Feb 3, 2020 | Feb 5, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 40.0 | -89,107 | -1.18% | ✓ | $3.1M |
| Jan 2, 2020 | Jan 6, 2020 | BridgeBio Pharma, Inc. | Officer | Sell | 40.0 | -120,000 | -1.57% | ✓ | $3.9M |